155 related articles for article (PubMed ID: 21412004)
1. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's disease.
Hubbuch M; Farmakis G; Schaefer A; Behnke S; Schneider S; Hellwig D; Fassbender K; Kirsch CM; Dillmann U; Spiegel J
Eur Neurol; 2011; 65(4):187-92. PubMed ID: 21412004
[TBL] [Abstract][Full Text] [Related]
2. Relationship between [
Ramani L; Malek N; Patterson J; Nissen T; Newman EJ
Acta Neurol Scand; 2017 Apr; 135(4):400-406. PubMed ID: 27255673
[TBL] [Abstract][Full Text] [Related]
3. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.
Eggers C; Kahraman D; Fink GR; Schmidt M; Timmermann L
Mov Disord; 2011 Feb; 26(3):416-23. PubMed ID: 21264942
[TBL] [Abstract][Full Text] [Related]
4. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
6. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
7. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
[TBL] [Abstract][Full Text] [Related]
8. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.
Yang Y; Cheon M; Kwak YT
Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
10. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
11. Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease.
Djaldetti R; Treves TA; Ziv I; Melamed E; Lampl Y; Lorberboym M
Neurol Sci; 2009 Aug; 30(4):301-5. PubMed ID: 19499179
[TBL] [Abstract][Full Text] [Related]
12. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
[TBL] [Abstract][Full Text] [Related]
13. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC
Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404
[TBL] [Abstract][Full Text] [Related]
14. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
15. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
16. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
[TBL] [Abstract][Full Text] [Related]
17. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
18. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
19. Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages.
Picillo M; Amboni M; Erro R; Vitale C; Longo K; Pellecchia MT; Cozzolino A; Moccia M; Allocca R; Barone P
Parkinsonism Relat Disord; 2013 Dec; 19(12):1143-8. PubMed ID: 24041938
[TBL] [Abstract][Full Text] [Related]
20. Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's disease.
Dorschner J; Farmakis G; Behnke S; Hellwig D; Schneider S; Fassbender K; Kirsch CM; Dillmann U; Spiegel J
Parkinsonism Relat Disord; 2011 Jun; 17(5):372-5. PubMed ID: 21421334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
